switching glp 1 agonists PDF] Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Capsule 61 - Therapeutic Interchange:

Non-Marketing SMS Messages If you select the non-marketing SMS checkbox, you may receive text messages related to: Driver applications Recruiting updates Interview scheduling Qualification follow-ups Document reminders Status updates Other job opportunity-related notifications Marketing SMS Messages If you select the marketing SMS checkbox, you may receive promotional text messages related to: Company news Service announcements Promotional updates Special offers SMS Terms Message frequency may vary Message and data rates may apply You can reply STOP to opt out at any time You can reply HELP for assistance Information Sharing No mobile information will be shared with third parties or affiliates for marketing or promotional purposes

A separate human study measured endogenous DSIP across normal subjects and patients with sleep apnea and narcolepsy, treating the compound as an endogenous marker rather than a confirmed therapeutic (PMID 8532601)

One study reported one rat out of 8 expressing human islet amyloid polypeptide (HIP) as a model for diabetes developed pancreatitis when treated with sitaglyptin for 12 weeks (70)

Science 335 , 16381643 (2012)